How does home management of asthma exacerbations by parents of inner- city children differ from NHLBI guideline recommendations?

Research output: Contribution to journalArticle

117 Citations (Scopus)

Abstract

Objectives. 1) To describe the asthma morbidity, primary care practices, and asthma home management of inner-city children with asthma; 2) to determine the responses of parental caretakers to asthma exacerbations in their child; and 3) to compare these responses to the recommendations of the National Heart, Lung, and Blood Institute (NHLBI) asthma guidelines for home management of acute exacerbations of asthma. Design and Methods. A 64-item telephone survey was administered between July 1996 and June 1997 to 220 parental caretakers of 2- to 12-year-old children who had been hospitalized with asthma at an inner-city medical center from January, 1995 to February, 1996. Sociodemographics, primary care practices, asthma morbidity, and asthma home management were assessed. Parents were asked what they would do if their child 'began wheezing and breathing faster than usual.' Results. Morbidity measures indicated that there were an average of 2.5 ± 4.5 emergency department visits for asthma in the last 6 months, 1.6 ± 2.2 hospitalizations for asthma in the last 12 months, and 18.1 ± 17.9 asthma- related school absences in the previous school year. Most, but not all, of the families had primary care providers and most had phone access to them. Half of the families (51%) reported having been given a written asthma action plan. Only 30% of families with children age 5 years and older had peak flow meters. In contrast, almost all families (97%) had equipment for inhalation of β-agonists. Only 39% of the 181 children with persistent symptoms were receiving daily antiinflammatory agents as recommended in the guidelines of the NHLBI. In response to the scenario of an acute exacerbation of asthma, no one mentioned that they would refer to a written plan, only 1 caretaker would measure peak flow and 36% would give β-agonists. Two percent would give oral steroids initially, and 1 additional person would do so if wheezing continued 40 minutes later. Only 4% responded that they would contact their clinician. Reports of actual practice differed from the scenario responses in that more people began β-agonists and oral steroids in response to an exacerbation in the past 6 months than said they would in response to the scenario. Conclusion. In this population of previously hospitalized inner-city children with asthma, the NHLBI guidelines for the home management of asthma exacerbations are not being followed. Interventions are needed to affect both clinician and caretaker practices.

Original languageEnglish (US)
Pages (from-to)422-427
Number of pages6
JournalPediatrics
Volume103
Issue number2
DOIs
StatePublished - Feb 1999

Fingerprint

National Heart, Lung, and Blood Institute (U.S.)
Asthma
Parents
Guidelines
Primary Health Care
Respiratory Sounds
Morbidity
Steroids

Keywords

  • β-agonist
  • Access to care
  • Antiinflammatory agents
  • Asthma
  • Children
  • Guidelines
  • Inner city
  • Management
  • Morbidity
  • Oral steroids
  • Peak flow
  • Scenario
  • Standard of care
  • Symptoms

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{b679a8f475ae41278a62a9625406a5b0,
title = "How does home management of asthma exacerbations by parents of inner- city children differ from NHLBI guideline recommendations?",
abstract = "Objectives. 1) To describe the asthma morbidity, primary care practices, and asthma home management of inner-city children with asthma; 2) to determine the responses of parental caretakers to asthma exacerbations in their child; and 3) to compare these responses to the recommendations of the National Heart, Lung, and Blood Institute (NHLBI) asthma guidelines for home management of acute exacerbations of asthma. Design and Methods. A 64-item telephone survey was administered between July 1996 and June 1997 to 220 parental caretakers of 2- to 12-year-old children who had been hospitalized with asthma at an inner-city medical center from January, 1995 to February, 1996. Sociodemographics, primary care practices, asthma morbidity, and asthma home management were assessed. Parents were asked what they would do if their child 'began wheezing and breathing faster than usual.' Results. Morbidity measures indicated that there were an average of 2.5 ± 4.5 emergency department visits for asthma in the last 6 months, 1.6 ± 2.2 hospitalizations for asthma in the last 12 months, and 18.1 ± 17.9 asthma- related school absences in the previous school year. Most, but not all, of the families had primary care providers and most had phone access to them. Half of the families (51{\%}) reported having been given a written asthma action plan. Only 30{\%} of families with children age 5 years and older had peak flow meters. In contrast, almost all families (97{\%}) had equipment for inhalation of β-agonists. Only 39{\%} of the 181 children with persistent symptoms were receiving daily antiinflammatory agents as recommended in the guidelines of the NHLBI. In response to the scenario of an acute exacerbation of asthma, no one mentioned that they would refer to a written plan, only 1 caretaker would measure peak flow and 36{\%} would give β-agonists. Two percent would give oral steroids initially, and 1 additional person would do so if wheezing continued 40 minutes later. Only 4{\%} responded that they would contact their clinician. Reports of actual practice differed from the scenario responses in that more people began β-agonists and oral steroids in response to an exacerbation in the past 6 months than said they would in response to the scenario. Conclusion. In this population of previously hospitalized inner-city children with asthma, the NHLBI guidelines for the home management of asthma exacerbations are not being followed. Interventions are needed to affect both clinician and caretaker practices.",
keywords = "β-agonist, Access to care, Antiinflammatory agents, Asthma, Children, Guidelines, Inner city, Management, Morbidity, Oral steroids, Peak flow, Scenario, Standard of care, Symptoms",
author = "Warman, {Karen L.} and Silver, {Ellen J.} and McCourt, {Mary P.} and Stein, {Ruth E. K.}",
year = "1999",
month = "2",
doi = "10.1542/peds.103.2.422",
language = "English (US)",
volume = "103",
pages = "422--427",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "2",

}

TY - JOUR

T1 - How does home management of asthma exacerbations by parents of inner- city children differ from NHLBI guideline recommendations?

AU - Warman, Karen L.

AU - Silver, Ellen J.

AU - McCourt, Mary P.

AU - Stein, Ruth E. K.

PY - 1999/2

Y1 - 1999/2

N2 - Objectives. 1) To describe the asthma morbidity, primary care practices, and asthma home management of inner-city children with asthma; 2) to determine the responses of parental caretakers to asthma exacerbations in their child; and 3) to compare these responses to the recommendations of the National Heart, Lung, and Blood Institute (NHLBI) asthma guidelines for home management of acute exacerbations of asthma. Design and Methods. A 64-item telephone survey was administered between July 1996 and June 1997 to 220 parental caretakers of 2- to 12-year-old children who had been hospitalized with asthma at an inner-city medical center from January, 1995 to February, 1996. Sociodemographics, primary care practices, asthma morbidity, and asthma home management were assessed. Parents were asked what they would do if their child 'began wheezing and breathing faster than usual.' Results. Morbidity measures indicated that there were an average of 2.5 ± 4.5 emergency department visits for asthma in the last 6 months, 1.6 ± 2.2 hospitalizations for asthma in the last 12 months, and 18.1 ± 17.9 asthma- related school absences in the previous school year. Most, but not all, of the families had primary care providers and most had phone access to them. Half of the families (51%) reported having been given a written asthma action plan. Only 30% of families with children age 5 years and older had peak flow meters. In contrast, almost all families (97%) had equipment for inhalation of β-agonists. Only 39% of the 181 children with persistent symptoms were receiving daily antiinflammatory agents as recommended in the guidelines of the NHLBI. In response to the scenario of an acute exacerbation of asthma, no one mentioned that they would refer to a written plan, only 1 caretaker would measure peak flow and 36% would give β-agonists. Two percent would give oral steroids initially, and 1 additional person would do so if wheezing continued 40 minutes later. Only 4% responded that they would contact their clinician. Reports of actual practice differed from the scenario responses in that more people began β-agonists and oral steroids in response to an exacerbation in the past 6 months than said they would in response to the scenario. Conclusion. In this population of previously hospitalized inner-city children with asthma, the NHLBI guidelines for the home management of asthma exacerbations are not being followed. Interventions are needed to affect both clinician and caretaker practices.

AB - Objectives. 1) To describe the asthma morbidity, primary care practices, and asthma home management of inner-city children with asthma; 2) to determine the responses of parental caretakers to asthma exacerbations in their child; and 3) to compare these responses to the recommendations of the National Heart, Lung, and Blood Institute (NHLBI) asthma guidelines for home management of acute exacerbations of asthma. Design and Methods. A 64-item telephone survey was administered between July 1996 and June 1997 to 220 parental caretakers of 2- to 12-year-old children who had been hospitalized with asthma at an inner-city medical center from January, 1995 to February, 1996. Sociodemographics, primary care practices, asthma morbidity, and asthma home management were assessed. Parents were asked what they would do if their child 'began wheezing and breathing faster than usual.' Results. Morbidity measures indicated that there were an average of 2.5 ± 4.5 emergency department visits for asthma in the last 6 months, 1.6 ± 2.2 hospitalizations for asthma in the last 12 months, and 18.1 ± 17.9 asthma- related school absences in the previous school year. Most, but not all, of the families had primary care providers and most had phone access to them. Half of the families (51%) reported having been given a written asthma action plan. Only 30% of families with children age 5 years and older had peak flow meters. In contrast, almost all families (97%) had equipment for inhalation of β-agonists. Only 39% of the 181 children with persistent symptoms were receiving daily antiinflammatory agents as recommended in the guidelines of the NHLBI. In response to the scenario of an acute exacerbation of asthma, no one mentioned that they would refer to a written plan, only 1 caretaker would measure peak flow and 36% would give β-agonists. Two percent would give oral steroids initially, and 1 additional person would do so if wheezing continued 40 minutes later. Only 4% responded that they would contact their clinician. Reports of actual practice differed from the scenario responses in that more people began β-agonists and oral steroids in response to an exacerbation in the past 6 months than said they would in response to the scenario. Conclusion. In this population of previously hospitalized inner-city children with asthma, the NHLBI guidelines for the home management of asthma exacerbations are not being followed. Interventions are needed to affect both clinician and caretaker practices.

KW - β-agonist

KW - Access to care

KW - Antiinflammatory agents

KW - Asthma

KW - Children

KW - Guidelines

KW - Inner city

KW - Management

KW - Morbidity

KW - Oral steroids

KW - Peak flow

KW - Scenario

KW - Standard of care

KW - Symptoms

UR - http://www.scopus.com/inward/record.url?scp=0033029940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033029940&partnerID=8YFLogxK

U2 - 10.1542/peds.103.2.422

DO - 10.1542/peds.103.2.422

M3 - Article

C2 - 9925835

AN - SCOPUS:0033029940

VL - 103

SP - 422

EP - 427

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 2

ER -